Lonza Sales AG

Part of Lonza Walkersville, Inc.

UEI
GWN2JBBJD574
CAGE
SR431
Primary NAICS
541714 Research and Development in Biotechnology (except Nanobiotechnology)
SAM.gov registration
Expired

Company facts

Self-certified in SAM.gov
  • For Profit Organization
  • Manufacturer of Goods
Entity structure
International Organization
Corporate family
SAM.gov registration date

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Contract awards

Award Agency Obligated Awarded
GS REA license renewal 4/12/2016/4/12/2017 HHSN272201600051PC National Institute of Allergy and Infectious Diseases (NIH) $7,279
GS expression system license for research purposes HHSN272201000348P NIAID DEA OA Acquisitions (NIH) $7,193

Contract subawards

Prime contractor Prime award Amount Awarded
Albert Einstein College Of Medicine Nhlbi catalyze program - preclinical services component - projects year 2 PO C000632105 75N92023F00001 $31,483
Albert Einstein College Of Medicine Nhlbi catalyze program - preclinical services component - projects year 2 PO C000632104 75N92023F00001 $54,897
Modernatx, Inc. DEVELOPMENT OF MRNA VACCINE TO LICENSURE FOR THE PREVENTION OF COVID-19. CLIN 0001 - PRE-AWARD COST, CLIN 0002 - DEVELOPMENT OF MRNA VACCINE TO BLA AND CLIN… 75A50120C00034 $41,813,293

Quick answers

Is Lonza Sales AG registered in SAM.gov?

Lonza Sales AG's SAM.gov registration expired on February 12, 2020.

What is Lonza Sales AG's most recent federal award?

Lonza Sales AG's most recent federal contract award is GS REA license renewal 4/12/2016/4/12/2017 (HHSN272201600051PC), from National Institute of Allergy and Infectious Diseases (NIH), on June 9, 2016.

On GovTribe

See Lonza Sales AG's full federal record

  • Federal contract awards
  • Subcontracting relationships
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login